China Resource Double-crane Pharmaceutical is a Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
Five production bases,GMP-Certified Manufacturer of APIs,With FDA, CEP, WHO etc China Resources Double-Crane Pharmaceutical Co., Ltd API Division has 5 production bases in total. At present, it has about 1300 employees. Main products: Varsaltan,Allopurinol,Isoniazid, Pregabalin,Nicotinamide, Bendazole Hydrochloride,Amlodipine Besylate,Terazosin HCL, Sulfamethazine,Olmesartan Medoxomil,Azilsartan,Pitavastatin Calcium, Sodium Nitroprusside,Triamterenum etc.
Company type
Generics/Biosimilars Manufacturer
Products and services
APIs (Active Pharmaceutical Ingredients)
Markets
North America (USA, Canada), Middle East Region (e.g. UAE), East Asia (e.g. China, Japan, Korea), Europe – EU countries, South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
China Resource Double-crane Pharmaceutical, No.1 Lizedonger Road, Wangjing, Chaoyang District, Beijing, China, 100102
